Flyte Aviation's Catheter Precision Publishes Comparative Study Evaluating Its LockeT Suture Retention Device Against A Traditional Internal Vascular Closure Device Following Large Bore Venous Access

Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE:VJET), today announced the first published comparative study evaluating its LockeT suture retention device against a traditional internal vascular closure device (VCD) following large bore venous access.

The 172-patient peer-reviewed study, titled "Vascular closure with a suture retention device versus suture-mediated closure system after large bore venous access for electrophysiologic procedures," was published in The Journal of Interventional Cardiology (JICE), a premier publication dedicated to original electrophysiology research and advanced ablation techniques.

The clinical data demonstrated the superior safety and efficacy of the LockeT device compared to Perclose, a leading internal VCD, manufactured and sold by Abbott. Key findings from the study include: